MedTrace Logo

Efficacy and Safety of Kinetin 0.1% for Treatment of Skin Photoaging

NCT01898182 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2014-09-15

No results posted yet for this study

Summary

The purpose of the study is to evaluate the change in the severity and clinical signs of skin photoaging among Filipino patients using Kinerase cream (Kinetin 0.1%). This study will recruit 132 subjects from dermatological clinics in a tertiary hospital in the Philippines for a period of 3 months (12 weeks). Changes in severity will be documented using physician evaluation, self-evaluation, and through VISIA complexion analysis system.

Conditions

  • Cutaneous Photoaging

Interventions

OTHER

Kinetin, N6-furfuryladenine, 0.1%

Sponsors & Collaborators

  • A. Menarini Philippines, Inc.

    collaborator INDUSTRY

  • Makati Medical Center

    lead OTHER

Principal Investigators

  • Ma. Purita P. Lao, MD, FPDS · Makati Medical Center

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-07-31
Completion
2014-09-30

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01898182 on ClinicalTrials.gov